Connecticut's 10-year, $100 million investment in stem-cell research has spawned some promising medical treatment breakthroughs and business opportunities, including one Farmington biotech startup trying to tackle treatments for multiple sclerosis.
A Glastonbury power plant engineering firm says it has accumulated a $750-million backlog of business, thanks to the industry's thirst for renewable and efficient energy projects.
Joe Hoke opens the front door for a visitor to the office-studio half of his home in Canton's Collinsville section, and steps inside. “Here's what I wanted to show you,'' Hoke says.
A trendy but tiny concept sweeping its way through housing developments in many major U.S. cities will land in Hartford as early as this year, just a few blocks from where UConn will build its downtown campus.
Q & A talks about Bioscience ClubhouseCT, a new initiative to spur development of the state's bioscience industry with Susan Froshauer, president and CEO of CURE, a bioscience trade group.